跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 470 条关于
“DT-9046”
全部
470
临床试验
275
药物
171
机构
1
资讯
23
7个月前
Kainova Therapeutics Raises $32M CAD to Advance GPCR-Targeting Cancer and Inflammation Therapies
去年
DT-109: Novel Glycine-Based Compound Shows Dual Efficacy Against Atherosclerosis and MASH
10个月前
Domain Therapeutics Initiates First-in-Human Trial of DT-7012 Anti-CCR8 Antibody for Advanced Solid Tumors
2个月前
Draig Therapeutics Secures $65M Series B to Advance DT-101 Phase 2 Trials in Major Depressive Disorder
6个月前
Kainova Therapeutics Reports Positive Phase I Results for Oral EP4 Receptor Antagonist DT-9081 in Advanced Solid Tumors
11个月前
Draig Therapeutics Receives FDA Clearance for Phase 2 Trial of Novel AMPA Receptor Modulator DT-101 in Major Depressive Disorder
2年前
Digital Twin Technology Mimics Standard of Care in Graft-vs-Host Disease Trial
去年
Design Therapeutics to Present Phase 1 Data for Novel FECD Eye Drop Treatment at Ophthalmology Conference
去年
Domain Therapeutics to Showcase Novel GPCR-Targeting Oncology Programs at AACR 2025
去年
Draig Therapeutics Emerges from Stealth with $140M to Advance Novel Neuropsychiatric Therapies
第 1 页,共 3 页
上一页
下一页